✦ LIBER ✦

Comparison of adjuvant activity of N- and C-terminal domain of gp96 in a Her2-positive breast cancer model

✍ Scribed by Nafiseh Pakravan; Zuhair Mohammad Hassan

Book ID: 107620389
Publisher: Springer Netherlands
Year: 2011
Tongue: English
Weight: 369 KB
Volume: 16
Category: Article
ISSN: 1355-8145
DOI: 10.1007/s12192-011-0258-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant activity of GP96 C-terminal dom

Adjuvant activity of GP96 C-terminal domain towards Her2/neuDNA vaccine is fusion direction-dependent

✍ Nafiseh Pakravan; Seyed Mahmoud Hashemi; Zuhair Mohammad Hassan 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 308 KB

Co-administration of GP96 and Her2/neuDN

Co-administration of GP96 and Her2/neuDNA vaccine in a Her2 breast cancer model

✍ Nafiseh Pakravan; Ladan Langroudi; Monire Hajimoradi; Zuhair Mohammad Hassan 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 329 KB

PCN81 A Cost-Effectiveness Analysis of A

PCN81 A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/NEU-Positive Breast Cancer in Colombia

✍ Buendia rodriguez, J.A.; Vallejos, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Adjuvant Trastuzumab Therapy In Her2-Pos

Adjuvant Trastuzumab Therapy In Her2-Positive Breast Cancer Patients: A Meta-Analysis Of Published Randomized Trials

✍ Xia, Y.; Bian, B.; Costea, E.; Kelton, C.M.; Guo, J.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Cost-effectiveness analysis of trastuzum

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t

Effect of adjuvant/neoadjuvant trastuzum

Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer

✍ Murthy, Rashmi K.; Varma, Ankur; Mishra, Priyankana; Hess, Kenneth R.; Young, El 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB